Histiocytosis X: a review of the etiology, pathology, staging, and therapy.
D000367:Age Factors; D001847:Bone Diseases / Q000628:therapy; D002675:Child, Preschool; D004359:Drug Therapy, Combination; D005260:Female; D006646:Histiocytosis, Langerhans-Cell / Q000209:etiology* / Q000473:pathology / Q000628:therapy; D006801:Humans; D007223:Infant; D007801:Langerhans Cells / Q000473:pathology; D008171:Lung Diseases / Q000628:therapy; D008297:Male; D015122:Mercaptopurine / Q000627:therapeutic use; D011241:Prednisone / Q000627:therapeutic use; D011379:Prognosis; D011879:Radiotherapy Dosage; D014747:Vinblastine / Q000627:therapeutic use
D014747:Vinblastine; D015122:Mercaptopurine; D011241:Prednisone